Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Int J Neuropsychopharmacol ; 18(7): pyv024, 2015 Mar 24.
Article in English | MEDLINE | ID: mdl-25805560

ABSTRACT

BACKGROUND: Feeding conditions can influence dopamine neurotransmission and impact behavioral and neurochemical effects of drugs acting on dopamine systems. This study examined whether eating high fat chow alters the locomotor effects of cocaine and dopamine transporter activity in adolescent (postnatal day 25) and adult (postnatal day 75) male Sprague-Dawley rats. METHODS: Dose-response curves for cocaine-induced locomotor activity were generated in rats with free access to either standard or high fat chow or restricted access to high fat chow (body weight matched to rats eating standard chow). RESULTS: Compared with eating standard chow, eating high fat chow increased the sensitivity of adolescent, but not adult, rats to the acute effects of cocaine. When tested once per week, sensitization to the locomotor effects of cocaine was enhanced in adolescent rats eating high fat chow compared with adolescent rats eating standard chow. Sensitization to cocaine was not different among feeding conditions in adults. When adolescent rats that previously ate high fat chow ate standard chow, sensitivity to cocaine returned to normal. As measured by chronoamperometry, dopamine clearance rate in striatum was decreased in both adolescent and adult rats eating high fat chow compared with age-matched rats eating standard chow. CONCLUSIONS: These results suggest that high fat diet-induced reductions in dopamine clearance rate do not always correspond to increased sensitivity to the locomotor effects of cocaine, suggesting that mechanisms other than dopamine transporter might play a role. Moreover, in adolescent but not adult rats, eating high fat chow increases sensitivity to cocaine and enhances the sensitization that develops to cocaine.


Subject(s)
Aging/psychology , Cocaine/pharmacology , Diet, High-Fat , Dopamine/metabolism , Eating/psychology , Locomotion/drug effects , Aging/metabolism , Animals , Behavior, Animal/drug effects , Body Weight/drug effects , Cocaine/administration & dosage , Diet, High-Fat/methods , Dopamine Uptake Inhibitors/administration & dosage , Dopamine Uptake Inhibitors/pharmacology , Dose-Response Relationship, Drug , Eating/drug effects , Male , Rats , Rats, Sprague-Dawley , Ventral Striatum/drug effects , Ventral Striatum/metabolism
2.
J Biol Chem ; 288(38): 27534-27544, 2013 Sep 20.
Article in English | MEDLINE | ID: mdl-23884410

ABSTRACT

The dopamine transporter (DAT) is responsible for sequestration of extracellular dopamine (DA). The psychostimulant amphetamine (AMPH) is a DAT substrate, which is actively transported into the nerve terminal, eliciting vesicular depletion and reversal of DA transport via DAT. Here, we investigate the role of the DAT C terminus in AMPH-evoked DA efflux using cell-permeant dominant-negative peptides. A peptide, which corresponded to the last 24 C-terminal residues of DAT (TAT-C24 DAT) and thereby contained the Ca(2+)-calmodulin-dependent protein kinase IIα (CaMKIIα) binding domain and the PSD-95/Discs-large/ZO-1 (PDZ)-binding sequence of DAT, was made membrane-permeable by fusing it to the cell membrane transduction domain of the HIV-1 Tat protein (TAT-C24WT). The ability of TAT-C24WT but not a scrambled peptide (TAT-C24Scr) to block the CaMKIIα-DAT interaction was supported by co-immunoprecipitation experiments in heterologous cells. In heterologous cells, we also found that TAT-C24WT, but not TAT-C24Scr, decreased AMPH-evoked 1-methyl-4-phenylpyridinium efflux. Moreover, chronoamperometric recordings in striatum revealed diminished AMPH-evoked DA efflux in mice preinjected with TAT-C24WT. Both in heterologous cells and in striatum, the peptide did not further inhibit efflux upon KN-93-mediated inhibition of CaMKIIα activity, consistent with a dominant-negative action preventing binding of CaMKIIα to the DAT C terminus. This was further supported by the ability of a peptide with perturbed PDZ-binding sequence, but preserved CaMKIIα binding (TAT-C24AAA), to diminish AMPH-evoked DA efflux in vivo to the same extent as TAT-C24WT. Finally, AMPH-induced locomotor hyperactivity was attenuated following systemic administration of TAT-C24WT but not TAT-C24Scr. Summarized, our findings substantiate that DAT C-terminal protein-protein interactions are critical for AMPH-evoked DA efflux and suggest that it may be possible to target protein-protein interactions to modulate transporter function and interfere with psychostimulant effects.


Subject(s)
Amphetamine/pharmacology , Cell-Penetrating Peptides/pharmacology , Central Nervous System Stimulants/pharmacology , Corpus Striatum/metabolism , Dopamine Plasma Membrane Transport Proteins/pharmacology , Dopamine/metabolism , Amphetamine/adverse effects , Animals , Benzylamines/pharmacology , Cell-Penetrating Peptides/metabolism , Central Nervous System Stimulants/adverse effects , Dopamine Plasma Membrane Transport Proteins/pharmacokinetics , Humans , Male , Mice , Motor Activity/drug effects , PDZ Domains , Protein Kinase C-alpha/antagonists & inhibitors , Protein Kinase C-alpha/metabolism , Protein Kinase Inhibitors/pharmacology , Sulfonamides/pharmacology
3.
Exp Dermatol ; 22(3): 236-8, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23489431

ABSTRACT

Traditional skin grafting techniques are effective but limited methods of skin replacement. Autologous transplantation of rapidly cultured keratinocytes is successful for epidermal regeneration, but the current gold-standard technique requires mouse fibroblast feeders and serum-rich media, with serum-free systems and dermal fibroblast (DF) feeders performing relatively poorly. Here, we investigated the capacity of human hair follicle dermal cells to act as alternative supports for keratinocyte growth. Dermal papilla (DP) dermal sheath (DS), DF and 3T3 cells were used as inactivated feeder cells for human keratinocyte coculture. Under conditions favouring dermal cells, proliferation of keratinocytes in the presence of either DS or DP cells was significantly enhanced compared with DF cells, at levels comparable to keratinocytes cultured under gold-standard conditions. Secreted protein acidic and rich in cysteine (SPARC) expression increased DS and DP cells relative to DFs; however, further experiments did not demonstrate a role in keratinocyte support.


Subject(s)
Cell Communication/physiology , Cell Proliferation , Dermis/cytology , Hair Follicle/cytology , Keratinocytes/cytology , 3T3 Cells/cytology , Animals , Coculture Techniques , Dermis/metabolism , Fibroblasts/cytology , Fibronectins/metabolism , Hair Follicle/metabolism , Humans , Keratinocytes/metabolism , Laminin/metabolism , Mice , Osteonectin , Skin Transplantation/physiology , Tumor Suppressor Proteins/metabolism
4.
Neuron ; 51(4): 417-29, 2006 Aug 17.
Article in English | MEDLINE | ID: mdl-16908408

ABSTRACT

Efflux of dopamine through the dopamine transporter (DAT) is critical for the psychostimulatory properties of amphetamines, but the underlying mechanism is unclear. Here we show that Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) plays a key role in this efflux. CaMKIIalpha bound to the distal C terminus of DAT and colocalized with DAT in dopaminergic neurons. CaMKIIalpha stimulated dopamine efflux via DAT in response to amphetamine in heterologous cells and in dopaminergic neurons. CaMKIIalpha phosphorylated serines in the distal N terminus of DAT in vitro, and mutation of these serines eliminated the stimulatory effects of CaMKIIalpha. A mutation of the DAT C terminus impairing CaMKIIalpha binding also impaired amphetamine-induced dopamine efflux. An in vivo role for CaMKII was supported by chronoamperometry measurements showing reduced amphetamine-induced dopamine efflux in response to the CaMKII inhibitor KN93. Our data suggest that CaMKIIalpha binding to the DAT C terminus facilitates phosphorylation of the DAT N terminus and mediates amphetamine-induced dopamine efflux.


Subject(s)
Amphetamines/pharmacology , Calcium-Calmodulin-Dependent Protein Kinases/pharmacology , Central Nervous System Stimulants/pharmacology , Dopamine Plasma Membrane Transport Proteins/metabolism , Dopamine/metabolism , Neurons/drug effects , Animals , Animals, Newborn , Benzylamines/pharmacology , Biological Transport/drug effects , Blotting, Western/methods , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Cells, Cultured , Chromatography, High Pressure Liquid/methods , Dopamine Plasma Membrane Transport Proteins/chemistry , Dopamine Plasma Membrane Transport Proteins/genetics , Enzyme Inhibitors/pharmacology , Humans , Immunohistochemistry/methods , Immunoprecipitation/methods , In Vitro Techniques , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mesencephalon/cytology , Neurons/physiology , Patch-Clamp Techniques/methods , Phosphorylation/drug effects , Protein Binding/drug effects , Protein Binding/physiology , Protein Structure, Tertiary/physiology , Rats , Sulfonamides/pharmacology , Transfection/methods
5.
Int J Neuropsychopharmacol ; 12(6): 731-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19419596

ABSTRACT

Efficacy of antidepressant drugs is often limited. One of the limiting factors may be diet. This study shows that the effect of escitalopram in the forced swimming test is diminished in rats by food restriction that decreased body weight by 8%. The primary target for escitalopram is the serotonin (5-HT) transporter. Using high-speed chronoamperometry to measure 5-HT clearance in vivo in rats fed the same food-restricted diet, the rate of 5-HT clearance from extracellular fluid in brain was dramatically increased. Increased 5-HT transporter function under conditions of dietary restriction might contribute to the decreased effect of escitalopram. These results suggest that diet plays an integral role in determining efficacy of antidepressant drugs, and might well generalize to other psychoactive drugs that impinge upon the 5-HT transporter.


Subject(s)
Brain/drug effects , Brain/metabolism , Citalopram/pharmacology , Food Deprivation/physiology , Selective Serotonin Reuptake Inhibitors/pharmacology , Serotonin/metabolism , Swimming , Analysis of Variance , Animals , Chromatography, High Pressure Liquid/methods , Electrochemistry/methods , Immobility Response, Tonic/drug effects , Male , Rats , Rats, Sprague-Dawley , Water/metabolism
6.
J Chem Neuroanat ; 83-84: 19-35, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28017803

ABSTRACT

The antidepressant-sensitive norepinephrine (NE) transporter (NET) inactivates NE released during central and peripheral neuronal activity by transport into presynaptic cells. Altered NE clearance due to dysfunction of NET has been associated with the development of mental illness and cardiovascular diseases. NET activity in vivo is influenced by stress, neuronal activity, hormones and drugs. We investigated the mechanisms of Ca2+ regulation of NET and found that Ca2+ influenced both Vmax and Km for NE transport into cortical synaptosomes. Changes in extracellular Ca2+ triggered rapid and bidirectional surface trafficking of NET expressed in cultured cells. Deletion of residues 28-47 in the NET NH2-terminus abolished the Ca2+ effect on surface trafficking. Mutagenesis studies identified Thr30 in this region as the essential residue for both Ca2+- dependent phosphorylation and trafficking of NET. Depolarization of excitable cells increased surface NET in a Thr30 dependent manner. A proteomic analysis, RNA interference, and pharmacological inhibition supported roles of CaMKI and CaMKII in Ca2+-modulated NE transport and NET trafficking. Depolarization of primary noradrenergic neurons in culture with elevated K+ increased NET surface expression in a process that required external Ca2+ and depended on CaMK activity. Hippocampal NE clearance in vivo was also stimulated by depolarization, and inhibitors of CaMK signaling prevented this stimulation. In summary, Ca2+ signaling influenced surface trafficking of NET through a CaMK-dependent mechanism requiring Thr30.


Subject(s)
Calcium Signaling/physiology , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Norepinephrine Plasma Membrane Transport Proteins/metabolism , Protein Transport/physiology , Threonine/metabolism , Animals , Brain/metabolism , Cell Line , Mice , Mice, Inbred C57BL , Rats , Rats, Sprague-Dawley
7.
J Neurosci ; 22(15): 6766-72, 2002 Aug 01.
Article in English | MEDLINE | ID: mdl-12151556

ABSTRACT

Serotonin uptake, mediated by the serotonin transporter (SERT), is blocked acutely by antidepressants such as the selective serotonin reuptake inhibitors (SSRIs), but such blockade does not correlate temporally with the onset of therapeutic improvement. Treatment with SSRIs for 21 d induced downregulation of the SERT (Benmansour et al., 1999). The time course of SERT downregulation as well as the time course for its recovery after cessation of treatment with the SSRI sertraline were investigated using tritiated cyanoimipramine to measure SERT binding sites. To determine if there was a temporal correlation between the time when sertraline induced downregulation of the SERT and when marked alteration in SERT function occurred, clearance of locally applied 5-HT into the CA3 region of hippocampus was achieved using in vivo electrochemistry. After 4 or 10 d treatment with sertraline, SERT binding sites decreased very little (15-30%), and the chronoamperometric signals for serotonin in sertraline-treated rats were comparable with ones obtained in control animals. By contrast, after 15 d of treatment, when SERT binding sites were markedly reduced by 80%, there was robust decrease in the clearance of 5-HT. Moreover, the functional consequences of SERT downregulation as measured by chronoamperometry were significantly greater than those seen after acute blockade of the SERT by SSRIs. SERT binding sites decreases are not a consequence of reduced SERT gene expression, as revealed by in situ hybridization measurements. SSRI-induced downregulation of the SERT may be a key component for the clinical response to SSRIs.


Subject(s)
Antidepressive Agents/pharmacology , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/metabolism , Down-Regulation/drug effects , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/metabolism , Membrane Transport Proteins , Nerve Tissue Proteins , Serotonin/metabolism , Animals , Binding, Competitive/drug effects , Carrier Proteins/genetics , Dose-Response Relationship, Drug , Hippocampus/drug effects , Hippocampus/metabolism , In Situ Hybridization , Male , Membrane Glycoproteins/genetics , RNA, Messenger/analysis , RNA, Messenger/metabolism , Raphe Nuclei/metabolism , Rats , Rats, Sprague-Dawley , Serotonin/pharmacokinetics , Serotonin Plasma Membrane Transport Proteins , Selective Serotonin Reuptake Inhibitors/pharmacology , Sertraline/pharmacology , Time
8.
PLoS One ; 8(3): e59788, 2013.
Article in English | MEDLINE | ID: mdl-23555781

ABSTRACT

Uptake through the Dopamine Transporter (DAT) is the primary mechanism of terminating dopamine signaling within the brain, thus playing an essential role in neuronal homeostasis. Deregulation of DAT function has been linked to several neurological and psychiatric disorders including ADHD, schizophrenia, Parkinson's disease, and drug addiction. Over the last 15 years, several studies have revealed a plethora of mechanisms influencing the activity and cellular distribution of DAT; suggesting that fine-tuning of dopamine homeostasis occurs via an elaborate interplay of multiple pathways. Here, we show for the first time that the ßγ subunits of G proteins regulate DAT activity. In heterologous cells and brain tissue, a physical association between Gßγ subunits and DAT was demonstrated by co-immunoprecipitation. Furthermore, in vitro pull-down assays using purified proteins established that this association occurs via a direct interaction between the intracellular carboxy-terminus of DAT and Gßγ. Functional assays performed in the presence of the non-hydrolyzable GTP analog GTP-γ-S, Gßγ subunit overexpression, or the Gßγ activator mSIRK all resulted in rapid inhibition of DAT activity in heterologous systems. Gßγ activation by mSIRK also inhibited dopamine uptake in brain synaptosomes and dopamine clearance from mouse striatum as measured by high-speed chronoamperometry in vivo. Gßγ subunits are intracellular signaling molecules that regulate a multitude of physiological processes through interactions with enzymes and ion channels. Our findings add neurotransmitter transporters to the growing list of molecules regulated by G-proteins and suggest a novel role for Gßγ signaling in the control of dopamine homeostasis.


Subject(s)
Dopamine Plasma Membrane Transport Proteins/metabolism , GTP-Binding Protein beta Subunits/metabolism , GTP-Binding Protein gamma Subunits/metabolism , Animals , Biotinylation , Brain/metabolism , Corpus Striatum/metabolism , Dopamine/metabolism , Dopamine Plasma Membrane Transport Proteins/antagonists & inhibitors , Glutathione Transferase/metabolism , Guanosine Triphosphate/metabolism , HEK293 Cells , Homeostasis , Humans , Immunoprecipitation , Mice , Mice, Inbred C57BL , Oocytes/cytology , Protein Structure, Tertiary , Signal Transduction , Synaptosomes/metabolism , Xenopus laevis
9.
PLoS One ; 7(11): e50742, 2012.
Article in English | MEDLINE | ID: mdl-23226372

ABSTRACT

Human multipotent skin derived precursor cells (SKPs) are traditionally sourced from dissociated dermal tissues; therefore, donor availability may become limiting. Here we demonstrate that both normal and diseased adult human dermal fibroblasts (DF) pre-cultured in conventional monolayers are capable of forming SKPs (termed m-SKPs). Moreover, we show that these m-SKPs can be passaged and that cryopreservation of original fibroblast monolayer cultures does not reduce m-SKP yield; however, extensive monolayer passaging does. Like SKPs generated from dissociated dermis, these m-SKPs expressed nestin, fibronectin and versican at the protein level. At the transcriptional level, m-SKPs derived from normal adult human DF, expressed neural crest stem cell markers such as p75NTR, embryonic stem cell markers such as Nanog and the mesenchymal stem cell marker Dermo-1. Furthermore, appropriate stimuli induced m-SKPs to differentiate down either mesenchymal or neural lineages resulting in lipid accumulation, calcification and S100ß or ß-III tubulin expression (with multiple processes). m-SKP yield was greater from neonatal foreskin cultures compared to those from adult DF cultures; however, the former showed a greater decrease in m-SKP forming capacity after extensive monolayer passaging. m-SKP yield was greater from adult DF cultures expressing more alpha-smooth muscle actin (αSMA). In turn, elevated αSMA expression correlated with cells originating from specimens isolated from biopsies containing more terminal hair follicles; however, αSMA expression was lost upon m-SKP formation. Others have shown that dissociated human hair follicle dermal papilla (DP) are a highly enriched source of SKPs. However, conversely and unexpectedly, monolayer cultured human hair follicle DP cells failed to form m-SKPs whereas those from the murine vibrissae follicles did. Collectively, these findings reveal the potential for using expanded DF cultures to produce SKPs, the heterogeneity of SKP forming potential of skin from distinct anatomical locations and ages, and question the progenitor status of human hair follicle DP cells.


Subject(s)
Dermis/cytology , Multipotent Stem Cells/cytology , Actins/metabolism , Adipogenesis , Adult , Biomarkers/metabolism , Cells, Cultured , Cryopreservation , Dermis/pathology , Female , Fibroblasts/cytology , Fibroblasts/pathology , Humans , Intermediate Filament Proteins/metabolism , Male , Middle Aged , Multipotent Stem Cells/metabolism , Nerve Tissue Proteins/metabolism , Nestin , Neurons/cytology , Osteogenesis , Schwann Cells/cytology , Up-Regulation , Versicans/metabolism
10.
J Neurochem ; 101(2): 389-96, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17250681

ABSTRACT

Cannabinoid drugs are known to affect dopaminergic neurotransmission in the basal ganglia circuitry. In this study, we used in vitro and in vivo techniques to investigate whether cannabinoid agonists and antagonist could affect dopaminergic transmission in the striatum by acting at the dopamine transporter. Incubation of striatal synaptosomes with the cannabinoid agonists WIN55,212-2 or methanandamide decreased dopamine uptake (IC(50) = 2.0 micromol/L and 3.1 micromol/L, respectively). A similar inhibitory effect was observed after application of the inactive WIN55,212-2 isomer, S(-)WIN55,212-3. The CB(1) antagonist AM251 did not reverse WIN55,212-2 effect but rather mimicked it. WIN55,212-2 and AM251 partially displaced the binding of the cocaine analog [(3)H]WIN35,428, thus acting as dopamine transporter pseudo-substrates in the high micromolar range. High-speed chronoamperometry measurements showed that WIN55,212-2 (4 mg/kg, i.p.) caused significant release of endogenous dopamine via activation of CB(1) receptors, followed by a reduction of dopamine clearance. This reduction was CB(1)-independent, as it was mimicked by S(-)WIN55,212-3. Administration of AM251 (1 and 4 mg/kg, i.p.) increased the signal amplitude and reduced the clearance of dopamine pressure ejected into the striatum. These results indicate that both cannabinoid agonists and antagonists inhibit dopamine transporter activity via molecular targets other than CB(1) receptors.


Subject(s)
Cannabinoids/agonists , Cannabinoids/antagonists & inhibitors , Corpus Striatum/drug effects , Dopamine Plasma Membrane Transport Proteins/drug effects , Dopamine/metabolism , Receptor, Cannabinoid, CB1/drug effects , Animals , Arachidonic Acids/pharmacology , Benzoxazines/pharmacology , Binding, Competitive/drug effects , Binding, Competitive/physiology , Cocaine/analogs & derivatives , Cocaine/pharmacology , Corpus Striatum/metabolism , Dopamine Plasma Membrane Transport Proteins/metabolism , Male , Metabolic Clearance Rate/drug effects , Metabolic Clearance Rate/physiology , Mice , Mice, Inbred C57BL , Morpholines/pharmacology , Naphthalenes/pharmacology , Piperidines/pharmacology , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Pyrazoles/pharmacology , Receptor, Cannabinoid, CB1/metabolism , Synaptosomes/drug effects , Synaptosomes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL